D. E. Shaw & Co., Inc. - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$6,904,138
-26.5%
668,358
-6.7%
0.01%
-30.0%
Q2 2023$9,391,716
+46.3%
716,378
+24.8%
0.01%
+42.9%
Q1 2023$6,419,154
+199.8%
574,164
+126.1%
0.01%
+250.0%
Q4 2022$2,141,136
+98.1%
253,990
+974.6%
0.00%
+100.0%
Q1 2021$1,081,00023,6360.00%
Other shareholders
PULMONX CORP shareholders Q2 2023
NameSharesValueWeighting ↓
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$886,0003.13%
PURA VIDA INVESTMENTS, LLC 1,327,065$19,534,0001.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,465,901$51,018,0001.05%
NEXT CENTURY GROWTH INVESTORS LLC 453,098$6,669,0000.87%
Novo Holdings A/S 510,555$7,515,0000.37%
Rock Springs Capital Management LP 702,400$10,339,0000.30%
RTW INVESTMENTS, LP 691,255$10,175,0000.26%
TimesSquare Capital Management, LLC 1,214,204$17,873,0000.25%
FORMULA GROWTH LTD 54,951$809,0000.22%
Champlain Investment Partners, LLC 2,129,760$31,350,0000.20%
View complete list of PULMONX CORP shareholders